Diazoxide
دیازوکساید
🧪 VariousInsulin-secretion inhibitor
Market / country: 🇺🇸 USA
Proglycem (US)
🧮 Dose calculator
Severe hypoglycaemia · Regimen source: FDA Proglycem · Dosage and Administration
- • Or in 2 doses every 12 h. Stop if ineffective after 2–3 weeks. FDA Proglycem · Dosage and Administration
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Functional hypoglycaemia; hypersensitivity to diazoxide or other thiazides. FDA Proglycem · Contraindications
Warnings
- • Fluid retention and heart failure; ketoacidosis and hyperosmolar coma; thiazides potentiate hyperglycaemia and hyperuricaemia. FDA Proglycem · Warnings
Formulations
- 50 mg/mL oral suspension — suspension 🇺🇸 USA FDA Proglycem · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Darooyab: category C — only if benefit outweighs risk. Darooyab · G-1632/Diazoxide-Oral — مصرف در بارداری
“مصرف در بارداری دیازوکساید خوراکی گروه C در شرايط خاص و نظارت ويژه پزشك قابل استفاده است:”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Proglycem · Nursing Mothers
“Information is not available concerning the passage of diazoxide in breast milk.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Proglycem · Pediatric Use
“See INDICATIONS AND USAGE .”
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA017453
- DailyMed (FDA label)FDA Proglycem
- MedlinePlus (NIH)Diazoxide Choline
- WHO ATC/DDDV03AH01
- Darooyab (Iran)Diazoxide-Oral
🇮🇷 Registered in Iran Darooyab · G-1632/Diazoxide-Oral
Dosage forms with Iranian generic codes, per Darooyab.
- 00421 · DIAZOXIDE 100MG CAP · کپسول دیازوکساید ۱۰۰ میلی‌گرم
- 05813 · DIAZOXIDE 100MG TAB · قرص دیازوکساید ۱۰۰ میلی‌گرم
- 01959 · DIAZOXIDE 25MG CAP · کپسول دیازوکساید ۲۵ میلی‌گرم
- 05812 · DIAZOXIDE 25MG TAB · قرص دیازوکساید ۲۵ میلی‌گرم
- 01463 · DIAZOXIDE 50MG CAP · کپسول دیازوکساید ۵۰ میلی‌گرم
- 13938 · DIAZOXIDE 50MG TAB · قرص دیازوکساید ۵۰ میلی‌گرم
- 00423 · DIAZOXIDE 50MG/5ML 30ML SYR · دیازوکساید ۵۰ میلی‌گرم / ۵ میلی‌لیتر ۳۰ میلی‌لیتر
- 52351 · DIAZOXIDE TABLET ORAL 50 mg · قرص دیازوکساید ۵۰ میلی‌گرم
- 52481 · DIAZOXIDE CAPSULE ORAL 25 mg · کپسول دیازوکساید ۲۵ میلی‌گرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Proglycem · How SuppliedFDA Proglycem · Dosage and AdministrationFDA Proglycem · WarningsFDA Proglycem · ContraindicationsFDA Proglycem · Nursing MothersFDA Proglycem · Pediatric UseFDA Proglycem · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1632/Diazoxide-OralDarooyab · G-1632/Diazoxide-Oral — مصرف در بارداری
- Clinical review⚠ Unverified